SCHEMBL7646277

SCHEMBL7646277

CC(c1cccc(C(=O)OC(C)(C)C)c1)N(CCCOS(C)(=O)=O)C(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.38
CASR P41180 2/20 0.36
STAT3 P40763 1/20 0.33
TP53BP1 Q12888 1/20 0.31
F2 P00734 4/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
CA14 Q9ULX7 1/20 0.31
TMPRSS6 Q8IU80 1/20 0.30
ACHE P22303 2/20 0.30
FAAH O00519 1/20 0.30
BCHE P06276 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7650960 0.92 RXRA (0.35) SLC7A5CASRCA12CA1CA2
SCHEMBL7648073 0.85 SLC7A5 (0.42) SLC7A5CASRSTAT3TP53BP1ACHE
SCHEMBL7646150 0.84 SLC7A5 (0.41) SLC7A5CASRSTAT3TP53BP1ACHE
SCHEMBL7646280 0.77 SLC7A5 (0.43) SLC7A5CASRSTAT3
SCHEMBL7647701 0.76 ANPEP (0.38) SLC7A5CASRTP53BP1
SCHEMBL14415230 0.74 SLC7A5 (0.51) SLC7A5STAT3F2CA12CA1
SCHEMBL7021584 0.73 SLC7A5 (0.46) SLC7A5CASRSTAT3F2CA12
SCHEMBL7021578 0.73 SLC7A5 (0.46) SLC7A5CASRSTAT3F2CA12
SCHEMBL3177799 0.72 L3MBTL1 (0.37) F2CA12CA1CA14CYP1A2
SCHEMBL7498901 0.71 SLC7A5 (0.53) SLC7A5STAT3F2CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002100871-A1 NEW COMPOUNDS USEFUL IN REFLUX DISEASE ASTRAZENECA AB (SE) 2002-12-19 WO claimed
WO-2002100871-A1 NEW COMPOUNDS USEFUL IN REFLUX DISEASE ASTRAZENECA AB (SE) 2002-12-19 WO disclosed